newsfilter
← Latest News
ACCESS Newswire·

Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Total revenue of $1.6M reported for Q3 Pivotal SUI PURSUIT trial enrollment nears completion - randomizations on-track for completion in Q4 ENGLEWOOD, CO / ACCESSWIRE / November 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology comp